StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Stock Performance
Milestone Scientific stock opened at $0.68 on Wednesday. The company’s fifty day moving average price is $0.67 and its 200 day moving average price is $0.66. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The stock has a market capitalization of $52.52 million, a P/E ratio of -6.80 and a beta of 0.90.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The company had revenue of $2.25 million during the quarter.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- Health Care Stocks Explained: Why You Might Want to Invest
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Best Stocks Under $5.00
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- 3 Small Caps With Big Return Potential
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
